Gilbert Seda1, Maria M Sanchez-Ortuno2,3, Carolyn H Welsh4,5, Ann C Halbower6, Jack D Edinger3,7. 1. Department of Pulmonary and Sleep Medicine, Naval Medical Center, San Diego, CA. 2. School of Nursing, University of Murcia, Murcia, Spain. 3. Department of Medicine, National Jewish Health, Denver, CO. 4. Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, CO. 5. Denver Veterans Affairs Medical Center, Denver, CO. 6. Department of Pulmonary Medicine, Children's Hospital Colorado and University of Colorado Denver, Denver, CO. 7. Duke University Medical Center, Durham, NC.
Abstract
STUDY OBJECTIVE: In this meta-analysis, we compare the short-term efficacy of prazosin vs. IRT on nightmares, sleep quality, and posttraumatic stress symptoms (PTSS). METHODS: Reference databases were searched for randomized controlled trials using IRT or prazosin for nightmares, sleep disturbance, and/or PTSS. Effect sizes were calculated by subtracting the mean posttest score in the control group from the mean posttest score in the treatment group, and dividing the result by the pooled standard deviation of both groups. Mixed effects models were performed to evaluate effects of treatment characteristics, as well as sample characteristics (veteran vs. civilian) on treatment efficacy. RESULTS: Four studies used prazosin, 10 used IRT alone or in combination with another psychological treatment, and 1 included a group receiving prazosin and another group receiving IRT. Overall effect sizes of both treatments were of moderate magnitude for nightmare frequency, sleep quality, and PTSS (p < 0.01). Effect size was not significantly different with type of treatment (psychological vs. pharmacological) on nightmare frequency (p = 0.79), sleep quality (p = 0.65), or PTSS, (p = 0.52). IRT combined with CBT for insomnia showed more improvement in sleep quality compared to prazosin (p = 0.03), IRT alone (p = 0.03), or IRT combined with another psychological intervention, (p < 0.01). CONCLUSION: Although IRT interventions and prazosin yield comparable acute effects for the treatment of nightmares, adding CBT for insomnia to IRT seems to enhance treatment outcomes pertaining to sleep quality and PTSS. More randomized clinical trials with long-term follow-up are warranted. COMMENTARY: A commentary on this article appears in this issue on page 9.
STUDY OBJECTIVE: In this meta-analysis, we compare the short-term efficacy of prazosin vs. IRT on nightmares, sleep quality, and posttraumatic stress symptoms (PTSS). METHODS: Reference databases were searched for randomized controlled trials using IRT or prazosin for nightmares, sleep disturbance, and/or PTSS. Effect sizes were calculated by subtracting the mean posttest score in the control group from the mean posttest score in the treatment group, and dividing the result by the pooled standard deviation of both groups. Mixed effects models were performed to evaluate effects of treatment characteristics, as well as sample characteristics (veteran vs. civilian) on treatment efficacy. RESULTS: Four studies used prazosin, 10 used IRT alone or in combination with another psychological treatment, and 1 included a group receiving prazosin and another group receiving IRT. Overall effect sizes of both treatments were of moderate magnitude for nightmare frequency, sleep quality, and PTSS (p < 0.01). Effect size was not significantly different with type of treatment (psychological vs. pharmacological) on nightmare frequency (p = 0.79), sleep quality (p = 0.65), or PTSS, (p = 0.52). IRT combined with CBT for insomnia showed more improvement in sleep quality compared to prazosin (p = 0.03), IRT alone (p = 0.03), or IRT combined with another psychological intervention, (p < 0.01). CONCLUSION: Although IRT interventions and prazosin yield comparable acute effects for the treatment of nightmares, adding CBT for insomnia to IRT seems to enhance treatment outcomes pertaining to sleep quality and PTSS. More randomized clinical trials with long-term follow-up are warranted. COMMENTARY: A commentary on this article appears in this issue on page 9.
Authors: B Krakow; M Hollifield; R Schrader; M Koss; D Tandberg; J Lauriello; L McBride; T D Warner; D Cheng; T Edmond; R Kellner Journal: J Trauma Stress Date: 2000-10
Authors: B Krakow; M Hollifield; L Johnston; M Koss; R Schrader; T D Warner; D Tandberg; J Lauriello; L McBride; L Cutchen; D Cheng; S Emmons; A Germain; D Melendrez; D Sandoval; H Prince Journal: JAMA Date: 2001-08-01 Impact factor: 56.272
Authors: Joan M Cook; Gerlinde C Harb; Philip R Gehrman; Mark S Cary; Geraldine M Gamble; David Forbes; Richard J Ross Journal: J Trauma Stress Date: 2010-10
Authors: T D Geracioti; D G Baker; N N Ekhator; S A West; K K Hill; A B Bruce; D Schmidt; B Rounds-Kugler; R Yehuda; P E Keck; J W Kasckow Journal: Am J Psychiatry Date: 2001-08 Impact factor: 18.112
Authors: Murray A Raskind; Elaine R Peskind; Evan D Kanter; Eric C Petrie; Allen Radant; Charles E Thompson; Dorcas J Dobie; David Hoff; Rebekah J Rein; Kristy Straits-Tröster; Ronald G Thomas; Miles M McFall Journal: Am J Psychiatry Date: 2003-02 Impact factor: 18.112
Authors: Gerlinde C Harb; Joan M Cook; Andrea J Phelps; Philip R Gehrman; David Forbes; Russell Localio; Ilan Harpaz-Rotem; Ruben C Gur; Richard J Ross Journal: J Clin Sleep Med Date: 2019-05-15 Impact factor: 4.062
Authors: Ye Zhang; Rong Ren; Larry D Sanford; Linghui Yang; Yuenan Ni; Junying Zhou; Jihui Zhang; Yun-Kwok Wing; Jie Shi; Lin Lu; Xiangdong Tang Journal: Sleep Med Date: 2019-06-22 Impact factor: 3.492
Authors: Peter J Colvonen; Laura D Straus; Carl Stepnowsky; Michael J McCarthy; Lizabeth A Goldstein; Sonya B Norman Journal: Curr Psychiatry Rep Date: 2018-06-21 Impact factor: 5.285